CRISPR-Cas9 has transformed genetic engineering across biology, but its implementation is far from universal. The molecular components that work elegantly in Escherichia coli or yeast often fail when transplanted into other organisms, because gene expression, plasmid maintenance and DNA repair differ from species to species. Bacillus species present particular challenges: their cell envelopes, restriction systems and regulatory quirks mean that editing protocols developed elsewhere frequently underperform or fail entirely. Existing CRISPR systems for Bacillus tend to be host-specific, meaning a vector tuned for Bacillus subtilis may not function in Bacillus licheniformis or Bacillus megaterium, forcing laboratories to maintain a separate toolkit for each strain they wish to modify.

The starting point for the new study was pJOE8999, a well-established vector-based CRISPR-Cas9 editing system that has served the Bacillus community for years. In its original form, pJOE8999 relies on an inducible promoter, typically activated by mannose, to drive expression of the Cas9 nuclease. Inducible control is valuable because Cas9 is toxic to cells: constant nuclease activity can cut the genome at unintended sites and even harm the cloning host in which the plasmid is first assembled. However, inducer-dependent systems add complexity and cost to every editing experiment, require careful timing of induction, and can behave inconsistently across species that differ in inducer uptake and metabolism.

To build an inducer-independent alternative, the team needed a promoter that would express Cas9 at levels high enough to drive efficient genome editing yet low enough to avoid poisoning the cell. Their solution drew on the conserved veg gene of Bacillus, which is transcribed by the housekeeping Sigma70-type RNA polymerase and provides a naturally calibrated level of expression in these bacteria. Rather than settling for a single promoter sequence, the researchers systematically created and screened variants of the veg promoter with different strengths, searching for a sweet spot where Cas9 production is sufficient to generate double-strand breaks at the targeted genomic locus but restrained enough to keep the editing plasmid tolerable both in Bacillus and in the E. coli strains used to clone it.

This promoter engineering proved to be the technical core of the project. By testing a panel of veg promoter variants, the team could match Cas9 expression to the demands of genome editing in a way that no longer depended on external induction. The result is a system that maintains the key advantages of the original design, namely low toxicity to both the target cell and the cloning host, and the convenience of a single-plasmid workflow, while shedding the inducer requirement that made the previous protocol more laborious. In practical terms, a researcher can now assemble the editing plasmid, transform it into the target Bacillus strain and let the cell’s own regulatory machinery handle Cas9 production, without adding mannose or any other trigger at a precise moment in the growth curve.

The versatility of the modified system was demonstrated across three different Bacillus species, a meaningful test given how often editing tools fail outside the species for which they were built. Successful gene deletions in all three organisms showed that the inducer-independent design is not a one-strain curiosity but a genuinely broad-host-range tool for this industrially important genus. The authors went further, using the system to integrate a reporter gene fusion into the genome and to introduce a single point mutation in Bacillus licheniformis. These are exactly the kinds of precise, small-scale edits that strain-development programs perform routinely, and the ability to make them with the same vector used for large deletions underscores the flexibility of the platform.

Speed and hands-on time were also central design goals. The researchers paired their plasmid with a one-step CRISPR-based transformation protocol, which enables fast genome editing workflows with minimal manual intervention. In conventional multi-step editing schemes, researchers must transform plasmid DNA, induce nuclease expression, allow homologous recombination or repair to occur, and then cure the cells of the editing vector before the next round of engineering. Each step adds days to the timeline and opportunities for failure. By consolidating delivery, expression and editing into a streamlined one-step procedure, the new system shortens the design-build-test cycles that dominate modern strain optimization, where the ability to iterate quickly often determines whether a project succeeds.

The industrial significance of the advance is difficult to overstate. Bacillus species are workhorses of industrial biotechnology: Bacillus subtilis and its relatives secrete large quantities of proteins, making them preferred hosts for enzyme production, while other members of the genus contribute to probiotics, agricultural products and biochemical synthesis. Strain improvement in these organisms traditionally depends on iterative rounds of genetic modification, and every inefficiency in the editing workflow multiplies across a development program. A single, reliable plasmid that works across multiple Bacillus species, requires no inducer and supports rapid one-step editing could therefore compress development timelines and reduce the specialized expertise needed to engineer these organisms, benefits that are especially attractive to companies such as BASF, which co-funded the study.

Beyond the immediate practical gains, the study illustrates a broader principle in synthetic biology: that the fine-tuning of gene expression, here through a panel of promoter variants, is often the decisive factor in porting a genetic tool between organisms. Rather than reinventing the CRISPR machinery, the team adapted an established vector by recalibrating one of its components to the biology of Bacillus. That strategy, screening promoter strengths to balance efficacy against toxicity, is likely to inform efforts to broaden the host range of editing systems in other industrially relevant microbes. As the authors note, advances in molecular biology tools are essential for streamlining and accelerating genetic engineering across industrial and academic applications, and this work offers a concrete example of how careful engineering of a single regulatory element can turn a specialized tool into a versatile platform.

Subject of Research: Development of an inducer-independent, single-plasmid CRISPR-Cas9 genome editing system for Bacillus species

Article Title: An inducer-independent, single-plasmid CRISPR-Cas9 system for genome editing in Bacillus species

Article References: Hilkmann, M., Welsch, N., Felle, M. F., Schweder, T., & Appelbaum, M. (2026). An inducer-independent, single-plasmid CRISPR-Cas9 system for genome editing in Bacillus species. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-026-14030-6

Image Credits: AI Generated

DOI: 10.1007/s00253-026-14030-6

Keywords: CRISPR-Cas9, genome editing, Bacillus, synthetic biology, industrial biotechnology, promoter engineering, strain optimization, pJOE8999, Bacillus subtilis, Bacillus licheniformis, metabolic engineering, plasmid vector